ArticleJournal for immunotherapy of cancer2018
Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy.
Guozhu Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this paperpooled itcites it